Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Journal of Molecular Biology|October 15, 2005
The effects of metal ions on the structure and stability of the DNA gyrase B proteinC Sissi, E Marangon, A Chemello, et al.Proceedings of the National Academy of Sciences of the United States of America|September 15, 1999
Interaction of calicheamicin gamma1(I) and its related carbohydrates with DNA-protein complexesC Sissi, J Aiyar, S Boyer, et al.Antimicrobial Agents and Chemotherapy|October 28, 2009
Mapping simocyclinone D8 interaction with DNA gyrase: evidence for a new binding site on GyrBC Sissi, E Vazquez, A Chemello, et al.Molecular Pharmacology|May 1, 1993
Sequence selectivity of topoisomerase II DNA cleavage stimulated by mitoxantrone derivatives: relationships to drug DNA binding and cellular effectsP De Isabella, G Capranico, M Palumbo, et al.Journal of Medicinal Chemistry|December 6, 1996
Potent 6-desfluoro-8-methylquinolones as new lead compounds in antibacterial chemotherapyV Cecchetti, A Fravolini, M Palumbo, et al.Anti-Cancer Drug Design|September 29, 1999
Binding of bis-substituted 2-aza-anthracenedione regioisomers to DNA: effects of the relative positioning of the side chainsC Sissi, S Moro, G Zagotto, et al.Journal of Natural Products|November 18, 2017
Role of the Benzodioxole Group in the Interactions between the Natural Alkaloids Chelerythrine and Coptisine and the Human Telomeric G-Quadruplex DNA. A Multiapproach InvestigationF Papi, M Ferraroni, R Rigo, et al.Journal of Molecular Biology|July 27, 2001
Ciprofloxacin affects conformational equilibria of DNA gyrase A in the presence of magnesium ionsC Sissi, E PerdonĂ , E Domenici, et al.Journal of Medicinal Chemistry|February 3, 1995
Chromophore-modified antitumor anthracenediones: synthesis, DNA binding, and cytotoxic activity of 1,4-bis[(aminoalkyl)amino]benzo[g]-phthalazine-5,10-dionesC A Gandolfi, G Beggiolin, E Menta, et al.Molecular Pharmacology|December 18, 1998
DNA-binding preferences of bisantrene analogues: relevance to the sequence specificity of drug-mediated topoisomerase II poisoningC Sissi, L Bolgan, S Moro, et al.Pageof 3